Chemotherapy I & 2 Flashcards
Anti-metabolic are __?__ phase specific and target __?__
S phase specific
Target DNA replication
Anti-metabolite tage acute or chronic cancers?
Acute
Name 3 anti-metaobolites
Methotrexate
5FU
Cytrabine (ara-C)
Methotrexate
Target
SE
Rescue drug
• Folic acid analogue supposed to stop dihydrofolate reductase (DHFR) • Derived from aminopterin • Uses o CNS o Lymphoma o Breast o H& N o Lung • Side Effects o Renal failure (alkanaized urine) o Rescued by leucovorin o Highly resistant (trimetrexate is new agent)p
- Lovocurine
- Methotrexate & potentiates the action of 5FU
5FU
mechanism
Use
Not a rescue but something that perpetuates the action of 5FU
• Inhibits Thymidylate synthase • Uses o Breast o GI • Leucovorin can potentiate action of 5FU
Cytarabine
Mechanism (does 2 things)
Severe SE
Use
• Nucleoside analogue (ribose converted to arabinose)
• Inhibits DNA polymerase alpha
• If incorporated into DNA: chain elongation & DNA ligation
• Uses
o AML (induction therapy with Daunorubicin)
o Lymphoma
• Side Effects
o Cerebellar toxicity
Alkylaing Angents Phase specific? Mechansim Dose response curve? SE Can cause?
- Bind DNA
- Phase non-specific
- Linear dose response curve
- Nausea
- Marrow suppression
- Mutagenesis
- Secondary cancers: AML & MDS (difficult to treat)
Name 3 alkylating agents
Mechlorethamine
Cyclophosphamide
Cisplatin
Cyclophasmpahide
- Use?
- Actived by which organ?
- Very specific SE?
- Rescued by?
• Most widely uses • Activated by liver p450 • Side effects o Hemorrhagic cystitis o caused by acrolein metabolite o Rescued by MESNA (2-mercaptoethane sulfonate)
Cisplating
- Mechanism
- Use
- SE (2)
• Bi-functional alkylating agent • Used in: breast, ovarian, head & neck cancers • Side effects - Renal insufficiency Neuropathy & hearing loss
Mechlorethamine
- This drug was the ?
- mechanism
- This drug is OK for use in
- SE
• G-cross linking • 1st chemotherapy agent • Non-enzymatic hydrolysis OK in patients with renal/hepatic failure • Myelosuppression is dose limiting • Secondary Cancer o Leukemia o Lymphoma o MDS
Difference between topoisomerase I & II
- Topoisomerase I: Single stranded DNA breaks
* Topoisomerase II: Double stranded breaks
Name the
1 Topo I inhibitor
Mechanism
Use
Epipodophyllotoxins Etoposide or VP-16
• Topo I inhibitor • Single stranded DNA breaks • Uses o Lung o Ovarian o Colorectal
Name the 2 Topo 2 inhibitors
Anthracycline
Daunorubicin Doxorubicin
Only SE of Epipodophyllotoxins
Etoposide or VP-16
• Neutropenia
Daunorubicin & danxorubicine
- Mechanism
- Uses
- SE
• Intercalate into DNA & bind G residues • Stabilizes DNA-Topo II intermediate • DNA fragmentation • Uses o Hematologic malignancies o Brest o Lung o GI o GU cancers • Side Effects o Hepatotoxicity o CHF o Vesicants (blisters)
Immunomodulatory Drugs
- Main SE
- Name the 3
- Which one is used to treat MM
• Thalidomide o GVHD o MM • Lenalidomide o MM o MDS o SE: Neuropathy • Pomalidomide o MM
Protesomal Inhbitors
- Name 2 agents
- Mechanism
- Uses
Velcade & Carfilzomib • Activates unfolded protein stress response pathway & apoptosis • Uses o Multiple myeloma o Mantle cell lymphoma
Microtubule Inhibitors
- Name 3 agents
- Which two share the same mechanism, describe that mechanism
- Mechanism of he 3rd
Vinblastine & vincristine
• M phase specific
• Bind tubulin
Taxol
• Stabilizes microtubules preventing depolymerization
Vinicristine (use male or female)
Viniblastine (male or female)
Vinicristine (female) • neuropathy Breast & cervix • Lung • Sarcoma • Lymphoma • Used with drugs whose primary toxicity in bone marrow related
Viniblastine (male) Uses • Testicular • Lymphoma SE • Bone marrow
Immune enhancing cytokines/growth factors
- IL-2: Melanoma & renal carcinoma
- IFNs (a, B, g): RCCs, NHL, melanoma, CML & MS
- SC administration
Bone marrow prolifereation
• G-CSF: MDS, neutropenia & severe infection
GM-CSF: MDS, neutropenia & severe infection
• Epo (rarely used): Anemia due to chemotherapy but worse outcomes with breast, NSC, H&N, lymphoid & cervical
• Thrombopoietin
• Subcutaneous or IV
• SE: bone pain, fever & headache, excess Epo can cause HTN & stroke
Rituximan & tiuxetan target
CD20
Gemtuzmab
CD33 immature myeloid cells AML
Cetuximab
- EGFR
- Colorectal
- H&N cancers
Bevacizumab
- VEGF
- Colorectal
- H&N
- Breast
- Kidney
Name the only DNA methylation agents
- Mechanism
- Uses
5-Azacytidine
• Induce cellular differentiation
• AML & MDS